Anti-Cytokeratin 20 antibody [Ks20.8], prediluted (ab962)

Publishing research using ab962? Please let us know so that we can cite the reference in this datasheet.

ab962 has been referenced in 8 publications.

  • Volkmer JP  et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A 109:2078-83 (2012). IHC-Fr ; Human . PubMed: 22308455
  • Fang DD  et al. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer 102:1265-75 (2010). Flow Cyt ; Human . PubMed: 20332776
  • Güçlü B  et al. Localization of Merkel cells in the monkey skin: an anatomical model. Somatosens Mot Res 25:123-38 (2008). PubMed: 18570016
  • Perry A  et al. Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum Pathol 28:938-43 (1997). PubMed: 9269830
  • Chan JK  et al. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 21:226-34 (1997). PubMed: 9042291
  • Maeda T  et al. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 9:901-9 (1996). PubMed: 8878022
  • Moll I  et al. Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent. J Invest Dermatol 104:910-5 (1995). PubMed: 7769257
  • Moll R  et al. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 53:75-93 (1993). PubMed: 8359595

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"